Abstract
We report the case of a 33-year-old man who presented with headaches and vomiting. Soon after admission he became drowsy and agitated, developed ventricular tachycardia and his neurological state worsened (Glasgow coma score 6). Blood analysis showed respiratory alkalosis, hyperlactacidemia (8 mmol/l), hyperammonemia (390 µmol/l) and hypoglycaemia (2.4 mmol/l). Subsequently, he developed supraventricular tachycardia, ventricular tachycardia and ultimately ventricular fibrillation resulting in cardiac arrest, which was successfully treated. A CT scan of the head revealed cerebral oedema. Whilst in the intensive care unit, he developed renal failure and rhabdomyolysis. The metabolic abnormalities seen at the time of admission normalised within 48 h with IV glucose infusion. Biological investigations, including urinary organic acids and plasma acylcarnitines, showed results compatible with MCAD deficiency. Mutation analysis revealed the patient was homozygous for the classical mutation A985G. This is one of only a few reports of severe cardiac arrhythmia in an adult due to MCAD deficiency. This condition is probably under-diagnosed in adult patients with acute neurological and/or cardiac presentations.
Similar content being viewed by others
References
Roe CR, Ding J (2001) Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2297–2326
Tanaka K, Gregersen N, Ribes A Kim J, Kolvraa S, Winter V, Eiberg H, Martinez G, Deufel T, Leifert B, Santer R, Francois B, Pronicka E, Laszlo A, Kmoch S, Kremensky I, Kalaydjicva L, Ozalp I, Ito M (1997) A survey of the newborn populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey and Japan for the G985 variant allele with haplotype analysis at the medium-chain acyl-CoA dehydrogenase gene locus: clinical and evolutionary considerations. Pediatr Res 41:201–209
Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, Yoon H, Madsen JA, Reyes-Mugica M, Rinaldo P (1998) Retrospective biochemical screening of fatty acid oxidation disorders in postmortem liver of 418 cases of sudden unexpected death in the first year of life. J Pediatr 132:924–933
Wilson CJ, Champion MP, Collins JE, Clayton PT, Leonard JV (1999) Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis. Arch Dis Child 80:459–462
Fromenty B, Mansouri A, Bonnefont JP, Courtois F, Munnich A, Rabier D, Pessayre D (1996) Most cases of medium-chain acyl-CoA dehydrogenase deficiency escape detection in France. Hum Genet 97:367–368
Ruitenbeek W, Poels PJE, Turnbul DM, Garavaglia B, Chalmers RA, Taylor RW, Gabreels FJM (1995) Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. J Neurol Neurosurg Psychiatry 58:209–214
Raymond K, Bale AE Barnes CA, Rinaldo P (1999) Medium-chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45-year-old woman. Genet Med 1:293-294
Bennett MJ, Powell S (1994) Metabolic disease and sudden, unexpected death in infancy. Hum Pathol 25:742–746
Oliver MF, Kurien VA, Greenwood TW (1968) Relation between serum free fatty acids and arrhytmias and death after acute myocardial infarction. Lancet 1:710–715
Rosenblatt-Velin N, Montessuit C, Papageorgiou I, Terrand J, Lerch R (2001) Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and down-regulation of genes of fatty acid metabolism. Cardiovasc Res 52:407–416
Fischbach PS, Corr PB, Yamada KA. (1992) Long-chain acylcarnitine increases intracellular Ca2+ and induces after depolarization in adult ventricular myocytes. Circulation 86:748
Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr (1967) Brain metabolism during fasting. J Clin Invest 46:1589–1595
Robinson AM, Williamson DH (1980) Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 60:143–187
Sanchez-Abarca LI, Tabernero A, Medina JM (2001) Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia 36:321–329
Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I (2001) Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res. 66:931–940
Saudubray JM, Ogier de Baulny H, Charpentier C (2000) Clinical approach to inherited metabolic diseases. In: Fernandes J, Saudubray JM, van den Berghe G (eds) Inborn metabolic diseases. Diagnosis and treatment. Springer-Verlag Berlin Heidelberg New York, pp 3–41
Liebl B, Fingerhut R, Roschinger W, Muntau A, Knerr I, Olgemoller B, Zapf A, Roscher AA (2000) Model project for updating neonatal screening in Bavaria: concept and initial results. Gesundheitswesen 62:189
Carpenter K, Wiley V, Sim KG, Heath D, Wilken B (2001) Evaluation of newborn screening for medium-chain acyl-CoA dehydrogenase deficiency in 275,000 babies. Arch Dis Child (Fetal Neonatal Ed) 85:105–109
Ziadeh R, Hoffman EP, Finegod DN, Hoop RC, Brackett JC, Strauss AW, Naylor EW (1995) Medium-chain acyl-Coa dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res 37:675–678
Iafolla AK, Thompson RJ, Roe CR (1994) Medium-chain acyl-CoA dehydrogenase deficiency: clinical course in120 affected children. J Pediatr 124:409–415
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feillet, F., Steinmann, G., Vianey-Saban, C. et al. Adult presentation of MCAD deficiency revealed by coma and severe arrythmias.. Intensive Care Med 29, 1594–1597 (2003). https://doi.org/10.1007/s00134-003-1871-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-003-1871-3